Wow! A 4.60% Dividend with 11.00% in upside potential?

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Secret Gold Back currency RUINING Biden's plans for a digital dollar?]( [There is a secret currency that’s beginning to spread across America. Click here now for details.]( --------------------------------------------------------------- December 4, 2023 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [Is Gold Really Boring?]( investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. [See why this could be a huge untapped gold investing opportunity.]( --------------------------------------------------------------- [Elevance Health]( Symbol: [ELV]( Recent Price: $483.12 Average Analyst Price Target: $572.00 (18.72%) Market Cap: $113.51B Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 21 2023 Expected Dividend & Yield: 1.18% Recent Analyst Action: Lisa Gill, analyst at J.P. Morgan, reiterates coverage on [Elevance Health (ELV)]( in the Healthcare sector with a Buy rating and a price target of $552 (2 weeks ago). [TipRanks.com]( also reports that [Elevance Health]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $572.00 . The target pricing ranges from a high forecast of $620 down to a low forecast of $552. [Elevance Health (ELV)](’s last closing price was $483.12 which would put the average price target at 18.72% upside. Here are 3rd party ratings for [ELV](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 32% (81 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Tech insider: "Watch your mailbox"]( You could soon get a strange package from the Federal Government. It's part of the biggest overhaul to our money in decades. And it could change your life (and retirement) in ways that'll surprise you. [Full story.]( --------------------------------------------------------------- [Cigna]( Symbol: [CI]( Recent Price: $269.02 Average Analyst Price Target: $341.00 (28.24%) Market Cap: $78.72B Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 21 2023 Expected Dividend & Yield: 1.79% Recent Analyst Action: Kevin Fischbeck, analyst at Bank of America Securities, reiterates coverage on [Cigna (CI)]( in the Healthcare sector with a Buy rating and a price target of $370 (3 days ago). [TipRanks.com]( also reports that [Cigna]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $341.00 . The target pricing ranges from a high forecast of $370 down to a low forecast of $323. [Cigna (CI)](’s last closing price was $269.02 which would put the average price target at 28.24% upside. Here are 3rd party ratings for [CI](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 23% (57 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Nvidia]( Symbol: [NVDA]( Recent Price: $467.65 Average Analyst Price Target: $648.00 (41.35%) Market Cap: $1.16T Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 28 2023 Expected Dividend & Yield: 0.03% Recent Analyst Action: Atif Malik, analyst at Citi, reiterates coverage on [Nvidia (NVDA)]( in the Technology sector with a Buy rating and a price target of $575 (3 days ago). [TipRanks.com]( also reports that [Nvidia]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $648.00 . The target pricing ranges from a high forecast of $685 down to a low forecast of $575. [Nvidia (NVDA)](’s last closing price was $467.65 which would put the average price target at 41.35% upside. Here are 3rd party ratings for [NVDA](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 14% (35 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Don't miss your 3rd and final chance!]( You missed your chance on Pfizer... ...which soared 600% after it released Lipitor in 1997. You missed your chance on Bristol Myers... ...which soared 500% after releasing Metformin in 1994. Both of these drugs broke records and made their investors rich. But there's one opportunity you didn't miss - and Morgan Stanley predicts it will be bigger than both of these combined! [Get all the details here.]( --------------------------------------------------------------- [Guess?, Inc.]( Symbol: [GES]( Recent Price: $22.82 Average Analyst Price Target: $25.67 (11.00%) Market Cap: $1.22B Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 22 2023 Expected Dividend & Yield: 4.60% Recent Analyst Action: Mauricio Serna, analyst at UBS, reiterates coverage on [Guess?, Inc. (GES)]( in the Consumer Cyclical sector with a Hold rating and a price target of $22 (1 week ago). [TipRanks.com]( also reports that [Guess?, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $25.67 . The target pricing ranges from a high forecast of $31 down to a low forecast of $22. [Guess?, Inc. (GES)](’s last closing price was $22.82 which would put the average price target at 11.00% upside. Here are 3rd party ratings for [GES](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Sell, Bottom 30% (176 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Barings BDC]( Symbol: [BBDC]( Recent Price: $9.06 Average Analyst Price Target: $9.80 (2.98%) Market Cap: $965.04M Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 13 2023 Expected Dividend & Yield: 11.04% Recent Analyst Action: Finian O'Shea, analyst at Wells Fargo, reiterates coverage on [Barings BDC (BBDC)]( in the Financial sector with a Hold rating and a price target of $8.5 (2 weeks ago). [TipRanks.com]( also reports that [Barings BDC]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.80 . The target pricing ranges from a high forecast of $9.5 down to a low forecast of $10. [Barings BDC (BBDC)](’s last closing price was $9.06 which would put the average price target at 2.98% upside. Here are 3rd party ratings for [BBDC](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 6% (15 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold is about to SOAR – here’s what you need to do]( is lining up perfectly for a historic gold bull run. One gold research firm says they’ve found the best way to get in, for less than $5. --------------------------------------------------------------- [Cedar Fair]( Symbol: [FUN]( Recent Price: $39.22 Average Analyst Price Target: $49.20 (23.23%) Market Cap: $2.00B Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 20 2023 Expected Dividend & Yield: 3.06% Recent Analyst Action: Steven Wieczynski, analyst at Stifel Nicolaus, reiterates coverage on [Cedar Fair (FUN)]( in the Consumer Cyclical sector with a Buy rating and a price target of $49 (1 week ago). [TipRanks.com]( also reports that [Cedar Fair]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $49.20 . The target pricing ranges from a high forecast of $51 down to a low forecast of $46. [Cedar Fair (FUN)](’s last closing price was $39.22 which would put the average price target at 23.23% upside. Here are 3rd party ratings for [FUN](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Bottom 42% (145 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Golden Ocean Group]( Symbol: [GOGL]( Recent Price: $9.69 Average Analyst Price Target: $10.10 (-3.30%) Market Cap: $1.93B Expected Ex-Dividend Date: Dec 05 2023 Expected Payment Date: Dec 13 2023 Expected Dividend & Yield: 7.74% Recent Analyst Action: Gregory Lewis, analyst at BTIG, reiterates coverage on [Golden Ocean Group (GOGL)]( in the Industrials sector with a Buy rating and a price target of $10 (1 week ago). [TipRanks.com]( also reports that [Golden Ocean Group]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.10 . The target pricing ranges from a high forecast of $8.7 down to a low forecast of $10. [Golden Ocean Group (GOGL)](’s last closing price was $9.69 which would put the average price target at -3.30% upside. Here are 3rd party ratings for [GOGL](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 30% (76 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Strategic Gold Play You Haven't Heard About]( recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. [Get the full story on this overlooked gold investment strategy here.]( --------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketMoverAlerts.com Disclaimer This email/newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this email/newsletter is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this email/newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our email/newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. [If you are not a human, click here.]( By opening and/or clicking on any link contained within this email, you are reconfirming your opt-in status. You can unsubsubscribe at any time by clicking on the link in the footer. MarketMoverAlerts.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software